0 items USD 0.00Search
Your search for "ark patent intelligence fulvestrant comprehensive patent search" gave back 165218 results.
The “Breast Cancer Generic Drugs Industry Forecast” looks at past sales and reviews total world Breast Cancer Generic Drugs sales in 2022, providing...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global Breast Cancer Generic Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform - Pipeline Review, H2 2019 Summary Phosphatidylinositol 4,5...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Biocurv Medical Instruments, Inc. - Strategy, SWOT and Corporate Finance Report Summary Biocurv Medical Instruments, Inc. - Strategy, SWOT and...
MarketLine
October 2022
Price: USD 175.00
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 - Drugs In Development, 2021 Summary Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Highlights The global Estrogen Receptor Beta market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications,...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals T-Cell Receptors (TCR) and Chimeric...
Catalog:
La Merie Publishing
May 2018
Price: USD 2,500.00
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases This Competitive Intelligence report about Bispecific Antibodies...
Catalog:
La Merie Publishing
June 2019
Price: USD 900.00
Non Alcoholic Fatty Liver Disease (NAFLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,500.00
The “ER Targeted Drugs for Breast Cancer Industry Forecast” looks at past sales and reviews total world ER Targeted Drugs for Breast Cancer sales in...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Highlights The global ER Targeted Drugs for Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The intelligent drug release system means that after the drug is delivered into the patient's body, it can be released at a fixed point and at...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Cyclin Dependent Kinase 4 - Pipeline Review, H2 2019 Summary Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
